申请人:Capet Marc
公开号:US20100249187A1
公开(公告)日:2010-09-30
The present invention relates to new compounds of formula (I) possessing agonistic activity at sphingosine-1-phosphate (S1P) receptors, their process of preparation and their use as immunosuppressive agents. The invention is also directed to pharmaceutical compositions containing these compounds and use of these compounds for treatment/prevention of immune mediated diseases and conditions or inflammatory diseases and conditions.
本发明涉及具有拟激活神经酰胺-1-磷酸(S1P)受体活性的新化合物(I)的配方,其制备过程以及作为免疫抑制剂的用途。本发明还涉及含有这些化合物的制药组合物以及使用这些化合物治疗/预防免疫介导的疾病和情况或炎症性疾病和情况的用途。